PharmaShots | Incisive News in 3 Shots

Subscribe Now

MSD

MSD’s Keytruda (pembrolizumab) Receives the NICE Recommendation for the Treatment of Triple-Negative Breast Cancer

MSD’s Keytruda (pembrolizumab) Receives the NICE Recommendation for the Treatment of Triple-Negative Breast Cancer

November 9, 2022

MSD Entered into a Clinical Trial Collaboration with SOTIO to Evaluate SOT101 + Keytruda (pembrolizumab) for the Treatment of Solid Tumors

MSD Entered into a Clinical Trial Collaboration with SOTIO to Evaluate SOT101 + Keytruda (pembrolizumab) for the Treatment of Soli...

December 9, 2021

PharmaShots Weekly Snapshots (October 25 - 29, 2021)

PharmaShots Weekly Snapshots (October 25 - 29, 2021)

October 29, 2021

PharmaShots Weekly Snapshots (August 02 - 06, 2021)

PharmaShots Weekly Snapshots (August 02 - 06, 2021)

August 6, 2021

PharmaShots Weekly Snapshots (June 21 - 25, 2021)

PharmaShots Weekly Snapshots (June 21 - 25, 2021)

June 25, 2021

PharmaShots Weekly Snapshots (April 26 - 30, 2021)

PharmaShots Weekly Snapshots (April 26 - 30, 2021)

April 30, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us